Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05296356 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

OSU6162 in Bipolar Depression (OBID)

Study acronym: OBID
StatusRecruiting
PhasePhase 2
Started2021-10-25
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 36 months later May 31, 2026 → May 31, 2029
See other at-risk trials from Göteborg University

Amendment history

2026-09-16
Primary completion pushed: 2026-05-31 → 2029-05-31
Completion pushed: 2027-05-31 → 2029-05-31
2025-03-19
Study Identification, Study Status, Study Description v2
Re-verified, no change to tracked fields
2023-10-02
Study Status v1
Primary completion date2023-05-31→2026-05-31
Completion date2023-09-30→2027-05-31
2022-03-24
Original filing
An explorative, open label, single armed, flexible dose, single center, phase IIa study of 8 weeks, initiated in subjects with bipolar depression. The study will consist of 9 visits and 1 safety visit. Subjects with a primary diagnosis of bipolar disorder (type 1 or 2) currently in an acute depressive phase (i.e. bipolar depression) and being on stable medication with at least one mood stabilizer.
Trial Details
NCT Number NCT05296356
Lead Sponsor Göteborg University
Collaborators: Arvid Carlsson Research AB
Conditions Bipolar Depression
Enrollment 22 participants
Start Date 2021-10-25
Primary Completion 2029-05-31 (estimated)
Study Completion 2029-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-09-15